Evidence map›Paper›PMID 40425445›Full record

ArticleThe journal of prevention of Alzheimer's disease2025

Association of multimorbidity and disease clusters with neuroimaging and cognitive outcomes in UK Biobank.

Shehab Uddin Al Abid, Catherine M Calvin, Danial Qureshi, Michele Veldsman, Elżbieta Kuźma, Thomas J Littlejohns

Abstract read
In one paragraph

Article in The journal of prevention of Alzheimer's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shehab Uddin Al AbidNuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK; Health Data Research UK, University of Oxford (HDRUK-Oxford), Oxford, UK. Electronic address: shehab.abid@ndph.ox.ac.uk.
Catherine M CalvinUK Biobank, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
Danial QureshiNuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
Michele VeldsmanPhD2B-Limited, Oxford, UK.
Elżbieta KuźmaAlbertinen Krankenhaus/Albertinen Haus gGmbH, Academic Teaching Hospital of the Faculty of Medicine, University of Hamburg, Hamburg, Germany.
Thomas J LittlejohnsNuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe relationship between multimorbidity, particularly disease clusters, with neuroimaging and cognitive outcomes that typically manifest prior to clinical diagnosis of dementia, remains understudied. This study investigated whether multimorbidity is associated with dementia-related neuroimaging and cognitive outcomes in the UK Biobank cohort.

methodsThis cross-sectional study used data from UK Biobank participants who attended imaging assessments between 2014-2023, and were free from neurological conditions, including dementia. Multimorbidity was defined as the coexistence of two or more long-term conditions, selected from a standardised criteria of 39 conditions. Latent class analyses were used to identify disease clusters. Neuroimaging outcomes were measured using magnetic resonance imaging, and cognition was assessed by seven tests measuring different cognitive domains. Multivariable linear regression was used to assess the association between multimorbidity and disease clusters with neuroimaging and cognitive outcomes.

resultsA total of 43,160 participants were included (mean [standard deviation] age, 64.2 [7.7] years, 53.1 % female). Multimorbidity was present among 14,339 (33.2 %) participants, and was associated with reduced grey matter volume, total brain volume, left hippocampal volume, increased cerebrovascular pathology as well as reduced domain-specific cognitive function. A strong dose-response relationship was observed with the increasing number of multimorbid conditions across these outcomes. A disease cluster driven by cardiometabolic conditions was consistently associated with poorer brain health across all outcomes. Disease clusters driven by respiratory, mental health and other conditions showed less consistent associations.

conclusionsMultimorbidity was strongly associated with poorer brain health, particularly within the cardiometabolic disease cluster. Given that UK Biobank participants are, on average, healthier than the general population, future studies in more diverse and representative cohorts would be valuable.

Indexed as

BrainCognitionCognitive DysfunctionDementiaMultimorbidityNeuroimagingAgedBiological Specimen BanksCross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedUK BiobankUnited KingdomBrain healthCognitive functionDisease clustersMultimorbidityNeuroimaging

Identifiers

PMID40425445
PMCPMC12321637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.